Pharmacy

Teva Pharmaceuticals will settle a San Francisco lawsuit, which accused the company of fueling the opioid epidemic in the city through the sale of highly addictive painkillers, for $24.8 million to be paid over 13 years, according to a July…

Kenilworth, N.J.-based Merck will pay Orion $290 million in a global development and commercialization agreement for the Finland-based pharmaceutical company's oral inhibitor that aims to treat advanced prostate cancer. 

With staffing shortages hindering healthcare systems, some are turning to robots to help understaffed workers — an effort that's paying off for Pittsburgh-based Allegheny Health Network, a 14-hospital system. 

Four pharmacy executive moves Becker's has covered since July 1:

Burlingame, Calif.-based pharmaceutical company Innoviva plans to write a check for $149 million to acquire La Jolla Pharmaceutical after both boards of directors approved the transaction. 

A new COVID-19 omicron subvariant, BA.2.75, has appeared amid a rising case count spurred by other variants, and early data suggests it's more transmissible than other strains. Here's what that could mean for vaccines. 

The following 10 hospitals, health systems and hospital operators have posted job listings seeking pharmacy leaders in the last week.

As vaccine-makers race to show promising results for their updated, omicron-targeted vaccines set to debut this fall, Moderna forged ahead to prove its candidate is nearly twice as effective as its original vaccine. 

The U.S. bought 3.2 million doses of Novavax's two-shot COVID-19 vaccine July 11 despite the vaccine-maker still waiting FDA authorization over the next few weeks. 

HRA Pharma is eyeing FDA approval to allow its daily birth control pill to forgo prescriptions. If it pans out, the over-the-counter drug would be the first of its kind.